Abstract:The growth and dissolution of calcium oxalate monohydrate (COM) were investigated by real-time in situ atomic force microscopy (AFM). The (100) surfaces of COM crystals were sufficiently rough that direct AFM imaging of terrace growth and step motion was not feasible. In undersaturated aqueous solutions, however, COM crystals dissolved, developing elongated hexagonal pits oriented along the [001] direction and having perimeters defined by {010} and {021} planes, which mimics the habit of the macroscopic crystals. Increasing the concentration of calcium oxalate to supersaturated levels reversed etching, resulting in gradual filling of the pits, which is tantamount to crystal growth. The confinement of growth within the pits permitted observation of crystal growth events, in real time and at the microscopic level, which could not be deduced by inspection of the rough surfaces of the COM crystals. This approach allowed determination of growth and dissolution rates along specific crystallographic directions, as well as the influence of solute concentration and additives on those rates. The polymeric additives tested were effective inhibitors of both COM growth and dissolution (pit filling and etching, respectively). Small amounts of poly(aspartate) (polyD) altered the aspect ratio of the (100) pits during growth and dissolution when compared to the behavior observed in the absence of polymer. The observed effects were consistent with preferential binding of the polymer to the {001} or {021} apical planes relative to the {010} planes. In contrast, poly(glutamate) (polyE), which was approximately 16 times less effective than polyD with respect to suppressing growth or dissolution, altered the aspect ratio in a manner consistent with preferred binding of polyE at the {010} surface. These observations provide a basis for understanding, and potentially regulating, calcium oxalate crystallization in important biomineralization processes, such as kidney stone formation.

Direct Nanoscale Imaging of Calcium Oxalate Crystallization on Brushite Reveals the Mechanisms Underlying Stone Formation

An Underlying Role of Brushite in Pathological Mineralization of Hydroxyapatite.

An Understanding of Renal Stone Development in a Mixed Oxalate-Phosphate System.

Inhibition of calcium oxalate monohydrate crystallization by the combination of citrate and osteopontin

Inhibition of Pathological Mineralization of Calcium Phosphate by Phosphorylated Osteopontin Peptides Through Step-Specific Interactions

Nanouric acid or nanocalcium phosphate as central nidus to induce calcium oxalate stone formation: a high-resolution transmission electron microscopy study on urinary nanocrystallites

Energetic Basis For Inhibition Of Calcium Phosphate Biomineralization By Osteopontin

Mechanisms of Modulation of Calcium Phosphate Pathological Mineralization by Mobile and Immobile Small-Molecule Inhibitors.

Modulation of Calcium Oxalate Dihydrate Growth by Phosphorylated Osteopontin Peptides.

Direct Visualization Of Calcium Oxalate Monohydrate Crystallization And Dissolution With Atomic Force Microscopy And The Role Of Polymeric Additives

Role of Hyperoxaluria/Hypercalciuria in Controlling the Hydrate Phase Selection of Pathological Calcium Oxalate Mineralization

The Interactions of Protein-Calcium Oxalate Within Crystallization Process

Modulation of calcium oxalate monohydrate crystallization by citrate through selective binding to atomic steps

In Situ Liquid‐Cell TEM Observation of Multiphase Classical and Nonclassical Nucleation of Calcium Oxalate

Novel Insights into Renal Mineralization and Stone Formation Through Advanced Imaging Modalities

Phosphorylation of Osteopontin is Required for Inhibition of Calcium Oxalate Crystallization.

The impact of crystal phase transition on the hardness and structure of kidney stones

Inhibition of Spiral Growth and Dissolution at the Brushite (010) Interface by Chondroitin 4-Sulfate.

Quantitative analysis of calcium oxalate monohydrate and dihydrate for elucidating the formation mechanism of calcium oxalate kidney stones

Tartronic Acid As a Potential Inhibitor of Pathological Calcium Oxalate Crystallization

Biological Modification in the Brushite Crystallization